---
input_text: "[Results of liver transplantations in Geneva or 32 consecutive transplantations
  without mortality in 2 years]. Between 1 january 1992 and 31 december 1993, 32 liver
  transplantations were performed in 29 patients (5 transplants in 3 children and
  27 transplants in 26 adults) at Geneva University Hospital. Despite 5 super-urgent
  transplantations (3 fulminant hepatitis, 1 end-stage Wilson disease and 1 primary
  nonfunction), all patients are still alive and all have lived more than 10 months.
  On 1 october 1994, all patients were at home and 93% were in good general condition.
  No patient of this series had been transplanted for cancer and all patients positive
  for hepatitis B surface antigen receive long-term administration of anti-HBs immune
  globulin: in this respect, the long-term mortality risk of the present series of
  patients seems to be very low. Although these results highlight that liver transplantation
  can be performed safely by a competent medico-surgical team, two significant difficulties
  have to be outlined. First, patients are likely to die on the waiting list due to
  unavailable grafts, especially in emergency cases. Second, the postoperative period
  of patients with decompensated end-stage liver disease at the time of liver transplantation
  is still one of high morbidity. These facts underline that chronic liver disease
  patient should be evaluated for liver transplantation prior to the terminal decompensated
  stage of the disease, when the candidate's invariably poor general condition precludes
  successful liver transplantation."
raw_completion_output: |-
  primary_disease: Liver Disease

  medical_actions: Liver transplantations; Administration of anti-HBs immune globulin

  symptoms: Decompensated end-stage liver disease; Fulminant hepatitis; End-stage Wilson disease; Primary nonfunction

  chemicals: Anti-HBs immune globulin

  action_annotation_relationships: Liver transplantations TREATS Decompensated end-stage liver disease IN Liver Disease; Liver transplantations TREATS Fulminant hepatitis IN Liver Disease; Liver transplantations TREATS End-stage Wilson disease IN Liver Disease; Liver transplantations TREATS Primary nonfunction IN Liver Disease; Administration of anti-HBs immune globulin (with Anti-HBs immune globulin) PREVENTS Hepatitis B recurrence IN Liver Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Administration of anti-HBs immune globulin (with Anti-HBs immune globulin) PREVENTS Hepatitis B recurrence IN Liver Disease

  ===

extracted_object:
  primary_disease: MONDO:0005154
  medical_actions:
    - MAXO:0001175
    - Administration of anti-HBs immune globulin
  symptoms:
    - Decompensated end-stage liver disease
    - HP:0004787
    - End-stage Wilson disease
    - Primary nonfunction
  chemicals:
    - Anti-HBs immune globulin
  action_annotation_relationships:
    - subject: <Liver transplantations>
      predicate: <TREATS>
      object: <Decompensated end-stage liver disease>
      qualifier: <Liver Disease>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <liver transplantations>
      object_extension: <Decompensated end-stage liver disease>
    - subject: MAXO:0001175
      predicate: TREATS
      object: HP:0004787
      qualifier: MONDO:0005154
    - subject: MAXO:0001175
      predicate: TREATS
      object: End-stage Wilson disease
      qualifier: MONDO:0005154
    - subject: MAXO:0001175
      predicate: TREATS
      object: Primary nonfunction
      qualifier: MONDO:0005154
    - subject: Administration of anti-HBs immune globulin
      predicate: PREVENTS
      object: Hepatitis B recurrence
      qualifier: MONDO:0005154
      subject_qualifier: with Anti-HBs immune globulin
      subject_extension: anti-HBs immune globulin
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001695
    label: Cardiac arrest
  - id: HP:0001685
    label: Myocardial fibrosis
  - id: HP:0001663
    label: Ventricular fibrillation
  - id: CHEBI:28694
    label: Copper
  - id: CHEBI:18248
    label: Iron
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: HP:0006554
    label: acute liver failure
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0009095
    label: zinc therapy
  - id: MAXO:0001298
    label: therapy
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001399
    label: Hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: HP:0003256
    label: coagulopathy (international normalized ratio >2.0)
  - id: HP:0004445
    label: hepatic encephalopathy (HE)
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: End-stage liver disease
  - id: HP:0100626
    label: End-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0000127
    label: Genetic testing
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000376
    label: liver biopsy
  - id: HP:0001404
    label: hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0001744
    label: Splenomegaly
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: impaired balance
  - id: HP:0001347
    label: hyperreflexia
  - id: HP:0031843
    label: bradyphrenia
  - id: HP:0002362
    label: shuffling gait
  - id: HP:0001621
    label: hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: pramipexole
  - id: CHEBI:2618
    label: amantadine
  - id: HP:0000093
    label: proteinuria
  - id: CHEBI:231592
    label: zinc salts
  - id: MAXO:0000167
    label: antiepileptic therapy
  - id: CHEBI:9168
    label: rapamycin
  - id: CHEBI:55379
    label: cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: HP:0000083
    label: renal failure
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: HP:0001342
    label: intracerebral hemorrhage
  - id: MAXO:0000533
    label: molecular genetic testing
  - id: HP:0001873
    label: thrombocytopenia
  - id: HP:0001298
    label: Encephalopathy
  - id: MAXO:0009070
    label: SPECT
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:166831
    label: copper chelators
  - id: MAXO:0035064
    label: electron microscopic studies
  - id: MAXO:0000139
    label: autopsy
  - id: HP:0006577
    label: macronodular cirrhosis
  - id: CHEBI:8830
    label: rhodanine
  - id: HP:0001272
    label: Cerebellar Atrophy
  - id: HP:0007263
    label: Spinocerebellar Ataxia
  - id: MAXO:0001610
    label: transcranial magnetic stimulation
  - id: HP:0002015
    label: dysphagia
  - id: HP:0001392
    label: liver disease
  - id: HP:0001396
    label: cholestasis
  - id: HP:0001403
    label: macrovesicular steatosis
  - id: CHEBI:90299
    label: orcein
  - id: MONDO:0000437
    label: Spinocerebellar degeneration
  - id: CHEBI:2948
    label: Azathioprine
  - id: CHEBI:8378
    label: Prednisolone
  - id: HP:0031690
    label: opportunistic infections
  - id: HP:0001397
    label: Steatosis
  - id: HP:0001513
    label: Obesity
  - id: HP:0000819
    label: Diabetes
  - id: HP:6000457
    label: Mallory bodies
  - id: HP:0002829
    label: Arthralgia
  - id: CHEBI:9907
    label: Ursodeoxycholic acid
  - id: MONDO:0007027
    label: Non-alcoholic steatohepatitis (NASH)
  - id: MONDO:0006507
    label: Hereditary hemochromatosis (HH)
  - id: MONDO:0018874
    label: Acute Myeloid Leukemia (AML)
  - id: CHEBI:41977
    label: Daunorubicin
  - id: CHEBI:28680
    label: Cytarabine
  - id: HP:0004808
    label: Acute Myeloid Leukemia (AML)
  - id: CHEBI:16856
    label: Glutathione (GSH)
  - id: CHEBI:53498
    label: Total antioxidant capacity (TAC)
  - id: CHEBI:566274
    label: Malondialdehyde (MDA)
  - id: HP:0001289
    label: Confusion
  - id: CHEBI:46195
    label: Acetaminophen
  - id: HP:0000989
    label: itchy skin
  - id: CHEBI:63623
    label: dimercaptosuccinic acid
  - id: CHEBI:145810
    label: insulin
  - id: MONDO:0003441
    label: dystonia
  - id: MAXO:0009015
    label: botulinum toxin injection
  - id: MAXO:0000943
    label: deep brain stimulation
  - id: HP:0004305
    label: involuntary movements
  - id: CHEBI:9720
    label: trihexyphenidyl
  - id: CHEBI:35474
    label: minor tranquilizers
  - id: HP:0005268
    label: spontaneous abortion
  - id: HP:0100520
    label: oliguria
  - id: CHEBI:16737
    label: creatinine
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0001250
    label: epileptic seizures
  - id: HP:0002315
    label: headache
  - id: CHEBI:6437
    label: levetiracetam
  - id: HP:0002878
    label: Acute respiratory failure
  - id: MONDO:0004789
    label: Cholangitis
  - id: CHEBI:33234
    label: Vitamin E
  - id: HP:0001953
    label: diabetic ketoacidosis (DKA)
  - id: HP:0001942
    label: metabolic acidosis
  - id: HP:0001946
    label: ketosis
  - id: HP:0003781
    label: Hypersalivation
  - id: HP:0002027
    label: Abdominal pain
  - id: HP:0002240
    label: Hepatomegaly
  - id: HP:0000707
    label: neurologic abnormalities
  - id: CHEBI:16796
    label: Melatonin
  - id: HP:0011967
    label: copper deficiency
  - id: HP:0100785
    label: Insomnia
  - id: HP:0003394
    label: Muscle cramps
  - id: HP:0003401
    label: Paresthesia
  - id: HP:0025406
    label: Weakness
  - id: CHEBI:4031
    label: Cyclosporine
  - id: CHEBI:8764
    label: Mycophenolate mofetil
  - id: MONDO:0019737
    label: Thrombotic microangiopathy (TMA)
  - id: HP:0002204
    label: Pulmonary embolism
  - id: HP:0100806
    label: Sepsis
  - id: HP:0001944
    label: dehydration
  - id: CHEBI:18291
    label: manganese
  - id: CHEBI:22984
    label: calcium
  - id: MAXO:0010026
    label: Zinc supplementation
  - id: HP:0033429
    label: Neuroinflammation
  - id: MONDO:0005071
    label: Neurological disorders
  - id: CHEBI:73925
    label: high-dose steroids (HDS)
  - id: HP:0001878
    label: Haemolytic anaemia
  - id: CHEBI:62984
    label: Zinc acetate
  - id: HP:0001875
    label: Neutropenia
  - id: MAXO:0001077
    label: splenectomy
  - id: HP:0005521
    label: local disseminated intravascular coagulation (DIC)
  - id: CHEBI:6888
    label: methylprednisolone
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: CHEBI:15544
    label: prostaglandin E1
  - id: HP:0001081
    label: cholelithiasis
  - id: HP:0002716
    label: lymphadenopathy
  - id: HP:0002040
    label: Esophageal varices
  - id: MONDO:0017014
    label: children
  - id: HP:0005912
    label: biliary atresia
  - id: HP:0200084
    label: neonatal hepatitis
  - id: HP:0031368
    label: bowel perforation
  - id: MONDO:0100192
    label: liver failure
  - id: HP:0001510
    label: growth retardation
  - id: CHEBI:3160
    label: Botulinum toxin type A (BoNT-A)
  - id: HP:0002344
    label: Neurologic deterioration
  - id: HP:0001882
    label: Leukopenia
  - id: HP:0003088
    label: Premature osteoarthritis (POA)
  - id: CHEBI:16990
    label: Bilirubin
  - id: MONDO:0021047
    label: Phyllodes tumor of the breast
  - id: HP:0001336
    label: myoclonus
  - id: HP:0002063
    label: rigidity
  - id: HP:0001402
    label: Hepatocellular carcinoma
  - id: HP:0002615
    label: Hypotension
  - id: HP:0002901
    label: Hypocalcaemia
  - id: HP:0012393
    label: Allergic reactions
  - id: MONDO:0005154
    label: Liver Disease
  - id: HP:0004787
    label: Fulminant hepatitis
